{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T13:27:02Z","timestamp":1787578022250,"version":"build-2736575974"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012940","name":"Universit\u00e4tsklinikum T\u00fcbingen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012940","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Achieving low intraocular pressure (IOP) while minimizing surgical risk remains a central challenge in the management of normal-tension glaucoma (NTG). This study aimed to evaluate the efficacy and safety of the Preserflo MicroShunt (PMS) in NTG compared with primary open-angle glaucoma (POAG) and the XEN-45 Gel Stent.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this retrospective dual-comparison study, the primary outcomes were 2-year complete success (\u2265\u200930% reduction in IOP from baseline and \u2264\u200912 mmHg without medication) and hazard ratios (HRs) for surgical failure. Kaplan\u2013Meier analyses and univariate Cox models were used to compare NTG PMS and POAG PMS patients (1:1 matched cohort; PMS analysis) and exploratory multivariable models for consecutive NTG PMS and NTG XEN-45 patients (NTG analysis). Secondary outcomes included bleb revision and complication rates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In the PMS analysis, 50 NTG patients were matched to 50 POAG patients. Two-year success rates were 69% and 45%, respectively (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0277). NTG diagnosis was associated with a lower risk of failure (HR 0.48, 95% CI 0.24\u20130.96) and fewer bleb revisions. In the NTG analysis, 45 PMS patients were compared with 23 XEN-45 patients. Two-year success rates were 71% and 17%, respectively (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001). PMS implantation was associated with a lower risk of failure (HR 0.25, 95% CI 0.12\u20130.53) and fewer needling procedures. No sight-threatening complications occurred in any group.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>PMS implantation enabled a high rate of sustained low IOP control, with significantly higher success rates than in matched POAG patients and NTG XEN-45 patients, while requiring fewer postoperative interventions. These findings indicate that the PMS might achieve lower IOP thresholds in NTG than previously expected requiring evaluation in larger prospective studies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12886-026-05254-1","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T17:24:07Z","timestamp":1787333047000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Achieving low intraocular pressure in normal-tension glaucoma with the Preserflo MicroShunt: comparison with primary open-angle glaucoma and the XEN-45 Gel Stent"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-3375-702X","authenticated-orcid":false,"given":"Emil","family":"Nasyrov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lasse","family":"Wolfram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix F.","family":"Reichel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline J.","family":"Wenzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogomil","family":"Voykov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,21]]},"reference":[{"issue":"4","key":"5254_CR1","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/S0002-9394(98)00272-4","volume":"126","author":"C Group","year":"1998","unstructured":"CNTGS Group. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Collaborative Normal-Tension Glaucoma Study Group. Am J Ophthalmol. 1998;126(4):498\u2013505.","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"5254_CR2","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/S0002-9394(98)00223-2","volume":"126","author":"C Group","year":"1998","unstructured":"CNTGS Group. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Collaborative Normal-Tension Glaucoma Study Group. Am J Ophthalmol. 1998;126(4):487\u201397.","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"5254_CR3","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1136\/bjophthalmol-2015-306872","volume":"100","author":"H Jayaram","year":"2016","unstructured":"Jayaram H, Strouthidis NG, Kamal DS. Trabeculectomy for normal tension glaucoma: outcomes using the Moorfields Safer Surgery technique. Br J Ophthalmol. 2016;100(3):332\u20138.","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"5254_CR4","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s10384-004-0181-9","volume":"49","author":"B Jongsareejit","year":"2005","unstructured":"Jongsareejit B, Tomidokoro A, Mimura T, Tomita G, Shirato S, Araie M. Efficacy and complications after trabeculectomy with mitomycin C in normal-tension glaucoma. Jpn J Ophthalmol. 2005;49(3):223\u20137.","journal-title":"Jpn J Ophthalmol"},{"issue":"6","key":"5254_CR5","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1136\/bjo.84.6.586","volume":"84","author":"WL Membrey","year":"2000","unstructured":"Membrey WL, Poinoosawmy DP, Bunce C, Hitchings RA. Glaucoma surgery with or without adjunctive antiproliferatives in normal tension glaucoma: 1 intraocular pressure control and complications. Br J Ophthalmol. 2000;84(6):586\u201390.","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"5254_CR6","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/IJG.0000000000000145","volume":"25","author":"SK Schultz","year":"2016","unstructured":"Schultz SK, Iverson SM, Shi W, Greenfield DS. Safety And Efficacy Of Achieving Single-Digit Intraocular Pressure Targets With Filtration Surgery In Eyes With Progressive Normal-Tension Glaucoma. J Glaucoma. 2016;25(2):217\u201322.","journal-title":"J Glaucoma"},{"issue":"3","key":"5254_CR7","doi-asserted-by":"publisher","first-page":"e779","DOI":"10.1111\/aos.14968","volume":"100","author":"KR Pillunat","year":"2022","unstructured":"Pillunat KR, Herber R, Haase MA, Jamke M, Jasper CS, Pillunat LE. PRESERFLO\u2122 MicroShunt versus trabeculectomy: first results on efficacy and safety. Acta Ophthalmol. 2022;100(3):e779\u201390.","journal-title":"Acta Ophthalmol"},{"key":"5254_CR8","doi-asserted-by":"crossref","unstructured":"Iwasaki K, Arimura S, Takamura Y, Inatani M. Clinical practice preferences for glaucoma surgery in Japan in 2024. J Clin Med 2025;14(6).","DOI":"10.3390\/jcm14062039"},{"issue":"11","key":"5254_CR9","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1038\/s41433-022-02326-6","volume":"37","author":"ML Kuet","year":"2023","unstructured":"Kuet ML, Azuara-Blanco A, Barton K, King AJ. Will the PRESERFLO\u2122 MicroShunt impact the future of trabeculectomy practice? A UK and \u00c9ire Glaucoma Society National Survey. Eye (Lond). 2023;37(11):2252\u20136.","journal-title":"Eye (Lond)"},{"issue":"8","key":"5254_CR10","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1007\/s00417-025-06843-4","volume":"263","author":"KS Lim","year":"2025","unstructured":"Lim KS, Garc\u00eda-Feij\u00f3o J, Klabe K. Management practices and surgical techniques for ab externo less invasive glaucoma surgery: a literature review and expert recommendations. Graefes Arch Clin Exp Ophthalmol. 2025;263(8):2149\u201361.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"5254_CR11","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s12886-024-03522-6","volume":"24","author":"E Nasyrov","year":"2024","unstructured":"Nasyrov E, Gassel CJ, Merle DA, Neubauer J, Voykov B. Long-term efficacy and safety of XEN-45 gel stent implantation in patients with normal-tension glaucoma. BMC Ophthalmol. 2024;24(1):264.","journal-title":"BMC Ophthalmol"},{"issue":"2","key":"5254_CR12","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.ogla.2021.07.008","volume":"5","author":"HJM Beckers","year":"2022","unstructured":"Beckers HJM, Aptel F, Webers CAB, Bluwol E, Mart\u00ednez-de-la-Casa JM, Garc\u00eda-Feijo\u00f3 J, Lachkar Y, M\u00e9ndez-Hern\u00e1ndez CD, Riss I, Shao H, et al. Safety and Effectiveness of the PRESERFLO\u00ae MicroShunt in Primary Open-Angle Glaucoma: Results from a 2-Year Multicenter Study. Ophthalmol Glaucoma. 2022;5(2):195\u2013209.","journal-title":"Ophthalmol Glaucoma"},{"issue":"2","key":"5254_CR13","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1097\/IJG.0000000000002509","volume":"34","author":"KR Pillunat","year":"2025","unstructured":"Pillunat KR, Herber R, Jamke M, Jasper CS, Haase MA, Manseck AS, Pillunat LE. Early Results of Preserflo MicroShunt for Primary Open Angle Glaucoma in White Patients. J Glaucoma. 2025;34(2):103\u201313.","journal-title":"J Glaucoma"},{"issue":"Suppl 1","key":"5254_CR14","first-page":"1","volume":"105","author":"European Glaucoma Society Terminology and Guidelines for Glaucoma","year":"2021","unstructured":"European Glaucoma Society Terminology and Guidelines for Glaucoma. 5th Edition. Br J Ophthalmol. 2021;105(Suppl 1):1\u2013169.","journal-title":"Br J Ophthalmol"},{"key":"5254_CR15","doi-asserted-by":"crossref","unstructured":"Nasyrov E, Seppelfricke C, Doycheva D, Gassel CJ, Merle DA, Voykov B. Preserflo MicroShunt implantation for glaucoma secondary to viral and juvenile idiopathic arthritis-related anterior uveitis. Ocul Immunol Inflamm 2024:1\u20138.","DOI":"10.1080\/09273948.2024.2436101"},{"key":"5254_CR16","volume-title":"Guidelines on design and reporting of glaucoma surgical trials","author":"T Shaarawy","year":"2009","unstructured":"Shaarawy T, Sheerwood MB, Grehn F. Guidelines on design and reporting of glaucoma surgical trials. Amsterdam, The Netherlands: Kugler; 2009."},{"issue":"7","key":"5254_CR17","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.ophtha.2024.01.008","volume":"131","author":"A Rabiolo","year":"2024","unstructured":"Rabiolo A, Triolo G, Khaliliyeh D, Jin SW, Morales E, Ghirardi A, Anand N, Montesano G, Virgili G, Caprioli J, et al. Hypotony Failure Criteria in Glaucoma Surgical Studies and Their Influence on Surgery Success. Ophthalmology. 2024;131(7):803\u201314.","journal-title":"Ophthalmology"},{"issue":"Suppl 1","key":"5254_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bjophthalmol-2023-egsguidelines","volume":"107","author":"L Abegao Pinto","year":"2023","unstructured":"Abegao Pinto L, Sunaric M\u00e9gevand G, Stalmans I, Azuara-Blanco A, Bron A, Garcia Feijoo J, Garway Heath T, Grehn F, King A, Kirwan J, et al. European Glaucoma Society - A guide on surgical innovation for glaucoma. Br J Ophthalmol. 2023;107(Suppl 1):1\u2013114.","journal-title":"Br J Ophthalmol"},{"issue":"18","key":"5254_CR19","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1212\/WNL.0000000000012777","volume":"97","author":"PC Austin","year":"2021","unstructured":"Austin PC, Yu AYX, Vyas MV, Kapral MK. Applying Propensity Score Methods in Clinical Research in Neurology. Neurology. 2021;97(18):856\u201363.","journal-title":"Neurology"},{"issue":"5","key":"5254_CR20","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1111\/jep.12072","volume":"19","author":"A Linden","year":"2013","unstructured":"Linden A, Samuels SJ. Using balance statistics to determine the optimal number of controls in matching studies. J Eval Clin Pract. 2013;19(5):968\u201375.","journal-title":"J Eval Clin Pract"},{"issue":"12","key":"5254_CR21","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1016\/0895-4356(95)00048-8","volume":"48","author":"P Peduzzi","year":"1995","unstructured":"Peduzzi P, Concato J, Feinstein AR, Holford TR. Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates. J Clin Epidemiol. 1995;48(12):1503\u201310.","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"5254_CR22","doi-asserted-by":"publisher","first-page":"e546","DOI":"10.1097\/IJG.0000000000000388","volume":"25","author":"R Van Ginderdeuren","year":"2016","unstructured":"Van Ginderdeuren R, Vandewalle E, Pinto LA, Stalmans I, Zeyen T. The Conjunctiva in Normal Tension Glaucoma Patients is Thinner Than in Primary Open-Angle Glaucoma Patients: A Comparative Histologic Study. J Glaucoma. 2016;25(5):e546\u2013549.","journal-title":"J Glaucoma"},{"key":"5254_CR23","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.ajo.2025.03.049","volume":"277","author":"T Hamanaka","year":"2025","unstructured":"Hamanaka T, Sakurai T, Kato T, Ishida N, Funaki T. Quantitative Evaluation of Trabecular Meshwork in Normal Tension Glaucoma Using Trabecular Meshwork Analyzing Software. Am J Ophthalmol. 2025;277:120\u201338.","journal-title":"Am J Ophthalmol"},{"key":"5254_CR24","doi-asserted-by":"crossref","unstructured":"Gambini G, Carl\u00e0 MM, Giannuzzi F, Boselli F, Grieco G, Caporossi T, De Vico U, Savastano A, Baldascino A, Rizzo C, et al. Anterior segment-optical coherence tomography bleb morphology comparison in minimally invasive glaucoma surgery: xen gel stent vs. preserflo MicroShunt. Diagnostics (Basel, Switzerland) 2022;12(5).","DOI":"10.3390\/diagnostics12051250"},{"issue":"7","key":"5254_CR25","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1111\/ceo.14407","volume":"52","author":"JN L\u00fcke","year":"2024","unstructured":"L\u00fcke JN, Dietlein TS, Widder RA, Roessler GF, L\u00fcke V, Enders P, Lappa A, Kiessling D. Matched case-control comparison of surgical success after XEN45 Gel Stent and PRESERFLO MicroShunt implantation in a Caucasian population. Clin Exp Ophthalmol. 2024;52(7):732\u20139.","journal-title":"Clin Exp Ophthalmol"},{"key":"5254_CR26","doi-asserted-by":"publisher","first-page":"932232","DOI":"10.3389\/fmed.2022.932232","volume":"9","author":"C Lai","year":"2022","unstructured":"Lai C, Shao SC, Chen YH, Kuo YK, Lai CC, Chuang LH. Trabeculectomy With Antimetabolite Agents for Normal Tension Glaucoma: A Systematic Review and Meta-Analysis. Front Med. 2022;9:932232.","journal-title":"Front Med"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-026-05254-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-026-05254-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-026-05254-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T12:51:12Z","timestamp":1787575872000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12886-026-05254-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5254"],"URL":"https:\/\/doi.org\/10.1186\/s12886-026-05254-1","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,21]]},"assertion":[{"value":"29 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the tenets of the Declaration of Helsinki. Ethical approval was granted by the ethics committee of the Medical Faculty of the University of Tuebingen which waived the requirement for patient consent for data to be used in this study due to the retrospective design (project numbers 074\/2023BO2 and 378\/2021BO2).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"EN has received a travel grant from Santen in October 2022. BV has received speaker honoraria and consultancy fees from Santen and AbbVie. LW, FFR and CJW declare no conflicts of interest.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"518"}}